USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
L

Treatment of RMD COVID-19 Patients: Are Anti-Rheumatic Drugs Proving Efficacy in Recovery? What Are the Current ACR Recommendations for COVID-19 Positive and Negative Patients?

By USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders FEATURING Leanna Wise
By USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders FEATURING Leanna Wise
372 views
November 24, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
18:24

New

Patient Advocay in Rheumatology - A Patient Story

Keck School of Medicine of USC

C. Ames

15:26

The Facts About COVID-19 Delta Breakthrough Infection and Vaccine Bo…

Cleveland Clinic Rheumatology and Immunology Series

L. Calabrese

6.4K views
01:58

The COVID-19 Global Rheumatology Alliance: Collecting Evidence-Based…

Covid-19 Global Rheumatology Alliance

P. Robinson, J. Yazdany

69 views
29:14

Cytokine Storm: Where Rheumatologists, Oncologists, and ID Meet

Cleveland Clinic Rheumatology

D. Fajgenbaum

185 views
14:51

Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…

ACR Convergence 2021 Coverage

S. Sattui Cortes

153 views
08:33

HCQ in Patients With Rheumatic Disease Complicated by COVID-19: Clar…

The Journal of Rheumatology

S. J. Balevic

96 views
07:43

Cleveland Clinic ACR 2020 Updates on COVID-19: Has Tocilizumab Prove…

Cleveland Clinic Rheumatology and Immunology Series

L. Calabrese

1.0K views
18:35

COVID-19 in RMD Patients: What Are the Risk Factors for Severe COVID…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

L. Wise

670 views
29:06

Vaccines for IMIDS: State of the Art

Cleveland Clinic Rheumatology

C. Calabrese

299 views
51:16

COVID-19 and Rheumatic Diseases

Yale School of Medicine

V. Chowdhary

143 views
24:32

Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of Labs …

RheumNow

J. Cush, R. Tate, Y. Yusof, B. Mehta, O. Petryna

195 views
19:39

Principles of Managing COVID-19 in High Risk Outpatients

Cleveland Clinic Rheumatology

C. Calabrese

134 views
22:24

JAK Inhibitors in the COVID-19 Era: Assessing the Risks and Benefit

Cleveland Clinic Rheumatology

K. Winthrop

100 views
05:35

Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection…

The Journal of Rheumatology

J. Curtis

85 views
22:39

The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment

The Journal of Rheumatology

E. Silverman, J. Rosenbaum, J. Reveille, K. Winthrop

64 views
20:38

COVID-19 and the Risks From Immunomodulatory Therapies

Cleveland Clinic Rheumatology

Z. Wallace

61 views
10:00

RheumNow Updates on Pemphigus Vulgaris, the Efficacy of JAK Inhibito…

RheumNow

J. Cush

60 views
05:29

Rheumatic Disease Patients with COVID-19: Is Timing Important for Bi…

RheumNow

J. Cush

54 views
26:25

Hyperinflammation and Immunomodulatory Drugs Trials in COVID-19

Cleveland Clinic Rheumatology

P. Mehta

48 views
14:08

Managing COVID-19 in Immune-Mediated Inflammatory Disease Patients: …

Cleveland Clinic Rheumatology

C. Calabrese, L. Calabrese, P. Mehta

34 views